BNP Paribas Financial Markets’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.2K Sell
5,321
-4,393
-45% -$50K ﹤0.01% 4729
2026
Q1
$110K Buy
9,714
+1,317
+16% +$14.3K ﹤0.01% 4325
2025
Q4
$108K Buy
8,397
+924
+12% +$11.4K ﹤0.01% 4341
2025
Q3
$83.5K Buy
7,473
+3,846
+106% +$37.1K ﹤0.01% 4376
2025
Q2
$36K Sell
3,627
-23,971
-87% -$235K ﹤0.01% 4371
2025
Q1
$259K Sell
27,598
-32,423
-54% -$341K ﹤0.01% 3569
2024
Q4
$550K Sell
60,021
-99,370
-62% -$731K ﹤0.01% 3239
2024
Q3
$1.24M Buy
159,391
+83,622
+110% +$604K ﹤0.01% 2367
2024
Q2
$458K Sell
75,769
-41,277
-35% -$255K ﹤0.01% 2714
2024
Q1
$687K Buy
117,046
+33,742
+41% +$200K ﹤0.01% 2682
2023
Q4
$653K Sell
83,304
-6,292
-7% -$43.6K ﹤0.01% 2648
2023
Q3
$655K Buy
89,596
+45,724
+104% +$380K ﹤0.01% 2577
2023
Q2
$458K Buy
43,872
+25,522
+139% +$246K ﹤0.01% 2626
2023
Q1
$190K Buy
18,350
+8,760
+91% +$112K ﹤0.01% 3165
2022
Q4
$132K Sell
9,590
-8,966
-48% -$125K ﹤0.01% 3147
2022
Q3
$380K Buy
18,556
+7,282
+65% +$160K ﹤0.01% 3160
2022
Q2
$218K Sell
11,274
-826
-7% -$16.9K ﹤0.01% 3044
2022
Q1
$261K Sell
12,100
-11,862
-50% -$269K ﹤0.01% 3039
2021
Q4
$661K Sell
23,962
-15,581
-39% -$430K ﹤0.01% 2860
2021
Q3
$1.03M Buy
39,543
+22,516
+132% +$602K ﹤0.01% 2355
2021
Q2
$462K Sell
17,027
-1,520
-8% -$37.1K ﹤0.01% 2564
2021
Q1
$434K Sell
18,547
-37,199
-67% -$752K ﹤0.01% 2643
2020
Q4
$855K Sell
55,746
-967
-2% -$12.3K ﹤0.01% 2124
2020
Q3
$684K Buy
56,713
+7,210
+15% +$68.4K ﹤0.01% 2016
2020
Q2
$503K Sell
49,503
-13,043
-21% -$134K ﹤0.01% 2096
2020
Q1
$652K Buy
62,546
+52,929
+550% +$664K ﹤0.01% 2202
2019
Q4
$154K Buy
9,617
+2,526
+36% +$38.6K ﹤0.01% 3083
2019
Q3
$131K Sell
7,091
-1,233
-15% -$24.1K ﹤0.01% 2973
2019
Q2
$164K Sell
8,324
-559
-6% -$11.4K ﹤0.01% 2735
2019
Q1
$203K Buy
8,883
+4,880
+122% +$106K ﹤0.01% 2692
2018
Q4
$80.6K Buy
4,003
+1,529
+62% +$31.6K ﹤0.01% 2472
2018
Q3
$53.8K Sell
2,474
-4,303
-63% -$95.6K ﹤0.01% 3011
2018
Q2
$151K Sell
6,777
-6,302
-48% -$129K ﹤0.01% 2578
2018
Q1
$226K Sell
13,079
-8,234
-39% -$137K ﹤0.01% 2722
2017
Q4
$354K Sell
21,313
-16
-0.1% -$273 ﹤0.01% 2680
2017
Q3
$365K Buy
21,329
+7,194
+51% +$121K ﹤0.01% 2140
2017
Q2
$229K Buy
14,135
+4,668
+49% +$73.8K ﹤0.01% 2369
2017
Q1
$164K Sell
9,467
-3,858
-29% -$64.5K ﹤0.01% 2304
2016
Q4
$225K Buy
13,325
+9,463
+245% +$158K ﹤0.01% 2145
2016
Q3
$67.7K Sell
3,862
-4,312
-53% -$69.9K ﹤0.01% 2294
2016
Q2
$117K Buy
8,174
+4,071
+99% +$50.9K ﹤0.01% 2071
2016
Q1
$50.4K Sell
4,103
-613
-13% -$6.77K ﹤0.01% 1998
2015
Q4
$57.3K Sell
4,716
-620
-12% -$7.63K ﹤0.01% 2715
2015
Q3
$70.4K Buy
5,336
+3,237
+154% +$48.9K ﹤0.01% 2628
2015
Q2
$34.4K Buy
2,099
+1,511
+257% +$25.1K ﹤0.01% 2713
2015
Q1
$10.5K Buy
+588
New +$10.9K ﹤0.01% 2723
2014
Q4
Sell
-1,456
Closed -$20K 2045
2014
Q3
$20K Buy
1,456
+1,342
+1,177% +$19.2K ﹤0.01% 3166
2014
Q2
$1.86K Buy
114
+67
+143% +$970 ﹤0.01% 3149
2014
Q1
$632 Sell
47
-276
-85% -$4.5K ﹤0.01% 2987
2013
Q4
$5.55K Buy
+323
New +$4.97K ﹤0.01% 3031

Other funds holding ANGO

BNP Paribas Financial Markets's ANGO Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its AngioDynamics (ANGO) stake by 45% in Q2 2026, selling an estimated $50K and leaving 5,321 shares worth $69.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4729.

BNP Paribas Financial Markets first reported a position in ANGO in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.24M in Q3 2024. 149 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • BNP Paribas Financial Markets held 5,321 shares of AngioDynamics worth $69.2K as of Q2 2026.
  • BNP Paribas Financial Markets sold 4,393 AngioDynamics shares in Q2 2026, an estimated $50K.
  • AngioDynamics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4729 holding.
  • BNP Paribas Financial Markets first reported a position in AngioDynamics in Q4 2013 and has held it in 50 quarters since.
  • BNP Paribas Financial Markets's AngioDynamics position peaked at $1.24M in Q3 2024.
  • 149 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.